Omega Healthcare Investors (OHI) 32.99 $OHI Technical

New Post Public Reply Private Reply Replies (0) Message Board

Jun 12, 2016 at 6:11 PM

Omega Healthcare Investors (OHI) 32.99 $OHI

Technical Pointers on REIT - Healthcare Facilities Equities -- Physicians Realty Trust, Omega Healthcare Investors, Healthcare Trust of America, and Care Capital Properties
PR Newswire - Mon Jun 06, 7:50AM CDT
On Friday, June 03, 2016, the NASDAQ Composite ended the trading session at 4,942.52, down 0.58%; the Dow Jones Industrial Average lost 0.18% to finish at 17,807.06; and the S&P 500 closed at 2,099.13, down 0.29%. ActiveWallSt.com has initiated coverage on the following equities: Physicians Realty Trust (NYSE: DOC), Omega Healthcare Investors Inc. (NYSE: OHI), Healthcare Trust of America Inc. (NYSE: HTA), and Care Capital Properties Inc. (NYSE: CCP). Learn more about these stocks by accessing their free trade alerts at:
OHI: 32.99 (-0.14), CCP: 26.36 (-0.36), DOC: 19.87 (+0.09), HTA: 31.37 (+0.16)

SmarTrend Watching for Potential Rebound in Shares of Omega Healthcare Investors After 1.84% Loss
Comtex SmarTrend(R) - Wed May 11, 3:24PM CDT
Omega Healthcare Investors (NYSE:OHI) traded in a range yesterday that spanned from a low of $32.41 to a high of $33.22. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $32.95 on volume of 944,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
OHI: 32.99 (-0.14)

After Yesterday's Decline of 1.68%, Omega Healthcare Investors Offers Investors Better Value
Comtex SmarTrend(R) - Fri May 06, 3:04PM CDT
Omega Healthcare Investors (NYSE:OHI) traded in a range yesterday that spanned from a low of $32.97 to a high of $33.75. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $33.79 on volume of 1.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
OHI: 32.99 (-0.14)

Omega Announces First Quarter 2016 Financial Results; Adjusted FFO of $0.83 Per Share for the First Quarter
BusinessWire - Wed May 04, 3:30PM CDT
Omega Healthcare Investors, Inc. (NYSE:OHI) (the "Company" or "Omega"

today announced its results of operations for the three-month period ended March 31, 2016. The Company also reported for the three-month period ended March 31, 2016 Funds From Operations ("FFO"

of $153.6 million or $0.77 per common share and Funds Available For Distribution ("FAD"

of $148.5 million or $0.75 per common share.
OHI: 32.99 (-0.14)

SmarTrend Watching for Potential Pullback in Shares of Omega Healthcare Investors After 1.43% Gain
Comtex SmarTrend(R) - Fri Apr 15, 2:33PM CDT
Omega Healthcare Investors (NYSE:OHI) traded in a range yesterday that spanned from a low of $34.99 to a high of $35.51. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $35.20 on volume of 478,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
OHI: 32.99 (-0.14)

Omega Announces Fifteenth Consecutive Increase in Its Quarterly Common Stock Dividend; Release Date of First Quarter Earnings and Conference Call; and Its Annual Meeting Date
BusinessWire - Thu Apr 14, 5:00PM CDT
Omega Healthcare Investors, Inc. (NYSE:OHI) today announced that the Company's Board of Directors declared a common stock dividend of $0.58 per share, increasing the quarterly common dividend by $0.01 per share over the previous quarter. The common stock dividend is payable Monday, May 16, 2016 to common stockholders of record as of the close of business on May 2, 2016.
OHI: 32.99 (-0.14)

3 Buy-Ranked REITs with Strong Fundamentals and Dividends
Maher Syed - Zacks Investment Research - Wed Mar 23, 4:58PM CDT
The REIT space looks optimistic in 2016. Here are three companies who look like dependable investment candidates.
OHI: 32.99 (-0.14), MNR: 12.82 (-0.04), PLD: 49.92 (+0.05)

Fitch Affirms Omega Healthcare Investors at 'BBB-'; Outlook Stable
BusinessWire - Mon Mar 21, 3:59PM CDT
Fitch Ratings has affirmed the ratings for Omega Healthcare Investors, Inc. (OHI) including the Issuer Default Rating (IDR) at 'BBB-'. In addition, Fitch has assigned a 'BBB-' rating to the $350 million senior unsecured term loan due 2021 entered into in January 2016. A full list of rating actions follows at the end of this release.
OHI: 32.99 (-0.14)

Top 3 Dividend Stocks with Great Growth Potential
Maher Syed - Zacks Investment Research - Thu Mar 17, 2:28PM CDT
the momentum has shifted for the better, but you should still protect yourself with income while you aim for profits.
ORA: 43.13 (-0.85), AEO: 15.51 (-0.45), OHI: 32.99 (-0.14)

Ventas (VTR) Upbeat on Demographics: Should You Hold?
Zacks Equity Research - Zacks Investment Research - Tue Mar 01, 3:20PM CST
On Feb 29, 2016, we issued an updated research report on Ventas Inc. (VTR), a Chicago -based healthcare real estate investment trust.
SBRA: 22.09 (-0.06), OHI: 32.99 (-0.14), PSB: 103.48 (-0.11), VTR: 68.58 (+0.16)

Omega Healthcare Investors reports 4Q results
Automated Insights - Wed Feb 10, 5:43PM CST
HUNT VALLEY, Md. (AP) _ Omega Healthcare Investors Inc. (OHI) on Wednesday reported a key measure of profitability in its fourth quarter. The results surpassed Wall Street expectations.
OHI: 32.99 (-0.14)

Omega Announces Fourth Quarter 2015 Financial Results; Adjusted FFO of $0.81 Per Share for the Fourth Quarter
BusinessWire - Wed Feb 10, 3:35PM CST
Omega Healthcare Investors, Inc. (NYSE:OHI) (the "Company" or "Omega"

today announced its results of operations for the three and twelve-month periods ended December 31, 2015. The Company also reported for the three-month period ended December 31, 2015 Funds From Operations ("FFO"

available to common stockholders of $127.4 million or $0.65 per common share and Funds Available For Distribution ("FAD"

to common stockholders of $143.0 million or $0.72 per common share.
AVIV: 36.75 (+0.25), OHI: 32.99 (-0.14)

Omega Healthcare Investors Shares Down 17.1% Since SmarTrend's Sell Call (OHI)
Comtex SmarTrend(R) - Wed Feb 10, 12:49PM CST
SmarTrend identified a Downtrend for Omega Healthcare Investors (NYSE:OHI) on January 14th, 2016 at $33.45. In approximately 4 weeks, Omega Healthcare Investors has returned 17.07% as of today's recent price of $27.74.
OHI: 32.99 (-0.14)

BUYINS.NET: OHI SqueezeTrigger Price is $27.56. There is $192,501,748 That Short Sellers Still Need To Cover.
M2 - Wed Feb 10, 9:20AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring Omega Healthcare Investors Inc (NYSE:OHI) in real time and just received an alert that OHI is crossing above its primary SqueezeTrigger Price, the price that a short squeeze can start in any stock. There are 6936500 shares that have been shorted at the volume weighted average SqueezeTrigger Price of $27.56. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com .
OHI: 32.99 (-0.14)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NSAP's First Board Aims to Revolutionize Autism Care

Out in Silicon Valley, where innovation isn’t just a buzzword, the National Society of Autism Professionals (NSAP) is stirring the pot with some serious leadership moves. Just this month, they cobbled together their inaugural board of directors—a gathering of eight experts from every corner of the autism field you can think of. They’re not playing small ball, no...

Tigermed's Strategic Shift: Privatization and Divestment

Hang onto your hats, folks, because Tigermed is shaking things up in a big way. The Chinese juggernaut you might know as Hangzhou Tigermed Consulting Co., Ltd. is throwing its hat in the ring for the privatization of Frontage Holdings. But that's not the end of the story—there's a whole restructuring circus coming to town, and they've got big plans to offload some...

RLX Technology Gears Up for Q3 Earnings Call Ahead

Under the Microscope: RLX Q3 2026 Earnings Get ready, because November 20 is shaping up to be a real event for RLX Technology watchers. The e-vapor heavyweight is gonna drop its Q3 results right before the crack of dawn U.S. markets open. Now, that's a time that stirs more coffee pots than debates—at 7:00 AM Eastern Time, to be precise. So, you better be braced for some...

Electra Defense's $4.7M Contract Fuels USAF Innovation

Electra's Latest Win: A $4.7M USAF Experiment Forget your typical aviation story, folks. Electra Defense just scored a whopping $4.7 million contract from the U.S. Air Force Research Laboratory. The goal? To push the boundaries of hybrid-electric aircraft tech, specifically their Ultra-Short Takeoff and Landing (Ultra-STOL) capabilities. This isn't about pie-in-the-sky...

Ribo Advances Lipid Disorder Strategy with SR122 Trial

Ribo's New Chapter in Lipid Disorders For those keeping tabs on the cutting-edge of lipid research, Ribo’s latest maneuver isn't one to skim over. The company, hailing from both Suzhou and Sweden, just moved forward by submitting its Phase I Clinical Trial Application in Europe for a fascinating compound: SR122. This development isn’t just another filing; it marks a...

CeQur Revolutionizes Insulin Delivery with Wearable Patch

A Patch to Simplify Mealtime Insulin So, it turns out CeQur is stepping up to the plate with their new wearable insulin patch called CeQur Simplicity. They just rolled it out nationally, and it's not your grandmother's insulin delivery method—this one sticks around for a whole week with some nifty up-to-1-unit dosing. If you're shoving insulin needles or pens into your...

Cepheid Expands Diagnostic Potential with IVDR Approval

A Key Milestone for Cepheid Breathing new life into Europe's diagnostic landscape, Cepheid's Xpert Respiratory Panel just snagged the CE marking under the IVDR. This ain't just some technical checkbox; this test's got the goods to spot 13 respiratory pathogens from one measly swab. It's a hefty lineup—think Adenovirus, different flavors of flu, and even the sneaky...

SOTERIA and Tempus Unite for Military Cancer Battle

The Military Faces Cancer's Grasp: A New Frontline There's a battle brewing in the healthcare world, one distinctly different from the chaos of stock tickers or quarterly earnings. It's about saving lives in a space where tactical precision is everything—cancer care for U.S. military personnel and veterans. SOTERIA Precision Medicine Foundation and Tempus (NASDAQ: TEM)...

Inner City Visions Celebrates Two Decades of Impact

Alfred Lomas' Transformation Fuels Lasting Change Once upon a time, Alfred Lomas was known as a brawler in the rough patches of South L.A., running with gangs and entangled in violence. But the story flipped, and instead of leaning into chaos, Lomas leaned into hope. That personal turnaround isn't just a headline—it's the crux behind Inner City Visions (ICV), the...

Trimble's New Machine Control Tech Promises Big Gains

Trimble's Latest Tech: A Game-Changer? The release of Trimble's MP1087 isn't just another upgrade—it's a leap forward. The folks over at Trimble decided to do some housekeeping with their machine positioning offerings, ditching separate components for a new all-in-one device. This bad boy doesn’t just promise—it delivers up to a 15% bump in uptime, even when...